Natural Alternatives International Inc (NAII) Stock Price & Analysis
Natural Alternatives International Inc (NAII) rose 3.45% to USD 2.4 as of July 25, 2026 at 04:52 UTC, according to Nexqual real-time market data.
NAII last closed at USD 2.32; the session ranged USD 2.32–2.4 on volume of 4,980 shares. Market capitalization is $15.06M, with a 52-week range of USD 2.09–4.96 (NGM). Source: Nexqual, July 25, 2026 at 04:52 UTC.
Key Statistics (as of July 25, 2026 at 04:52 UTC)
| Price | USD 2.4 |
|---|---|
| Change | ▲ 3.45% (up) |
| Previous Close | USD 2.32 |
| Open | USD 2.32 |
| Day Range | USD 2.32 – 2.4 |
| 52-Week Range | USD 2.09 – 4.96 |
| Volume | 4,980 shares |
| Market Cap | $15.06M |
| Exchange | NGM |
Technical Analysis (NAII)
Nexqual's technical model rates NAII "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 04:52 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 54.78 (neutral) |
| vs SMA50 | Below (USD 2.45) |
| MACD | -0.04 (negative) |
Analyst Ratings (NAII)
Wall Street analysts rate NAII "None", per Nexqual as of July 25, 2026 at 04:52 UTC.
| Consensus Rating | None |
|---|
Earnings (NAII)
Source: Nexqual, July 25, 2026 at 04:52 UTC.
Financials & Fundamentals (NAII)
| Total Revenue | $141.87M |
|---|---|
| Revenue Growth (YoY) | +23.30% |
| Gross Margin | +7.62% |
| Operating Margin | -11.31% |
| Profit Margin | -10.13% |
| ROE | -20.57% |
| Debt / Equity | 103.26 |
| Current Ratio | 1.64 |
| Total Cash | $9.20M |
| Total Debt | $65.17M |
| Free Cash Flow | $-3.00M |
Source: Nexqual, July 25, 2026 at 04:52 UTC.
Financial Health Score (NAII)
Nexqual rates Natural Alternatives International Inc's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 04:52 UTC.
| Growth | Strong — Revenue +23% YoY (latest Q) |
|---|---|
| Profitability | Critical — Gross margin 8%, operating -11% |
| Balance Sheet | Mixed — $9M cash vs $65M debt |
| Cash Flow | Weak — FCF negative: -$3M, burning cash |
| Efficiency | Critical — ROE -21%, ROA -2.5% |
Ownership (NAII)
| Insider Ownership | +21.68% |
|---|---|
| Institutional Ownership | +34.98% |
| Shares Outstanding | 6.28M |
| Float | 4.93M |
| Short % of Float | +0.13% |
Source: Nexqual, July 25, 2026 at 04:52 UTC.
Leadership (NAII)
Natural Alternatives International Inc is led by Mark A. LeDoux (age 71), Chairman of the Board & CEO, per Nexqual as of July 25, 2026 at 04:52 UTC.
| Chairman of the Board & CEO | Mark A. LeDoux (age 71) |
|---|---|
| President, COO, Secretary, Principal Financial & Principal Accounting Officer | Kenneth E. Wolf (age 64) |
| Vice President of Global Sales | Shane Conti |
Major Backers & Investors (NAII)
Notable institutional backers of Natural Alternatives International Inc include Caldwell Sutter Capital, Inc., Mink Brook Asset Management LLC , Renaissance Technologies, according to Nexqual as of July 25, 2026 at 04:52 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Caldwell Sutter Capital, Inc. | 7.95% |
| Mink Brook Asset Management LLC | 4.68% |
| Renaissance Technologies | 4.64% |
| Morgan Stanley | 4.27% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 3.79% |
| Bridgeway Capital Management, LLC | 1.2% |
| Bridgeway Funds, Inc.-Ultra-Small Company Market Fund | 0.79% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 7.15% |
| Dimensional Fund Advisors | 5.92% |
| Geode Capital | 0.84% |
Source: Nexqual, July 25, 2026 at 04:52 UTC.
From Natural Alternatives International Inc's Latest SEC 10-K Filing (filed 2025-09-23)
Key Strengths & Strategy (as disclosed to the SEC)
- Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally.
- It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing.
- The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.
- In addition, the company sells beta-alanine ingredient under the CarnoSyn, TriBsynm, and SR CarnoSyn names.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NATR | Nature's Sunshine Products, Inc | USD 20.4 | ▼ 2.02% |
| NUTR | Nusatrip Incorporated | USD 9 | ▲ 0% |
| MTEX | Mannatech, Incorporated | USD 4.5 | ▲ 2.74% |
| ICCC | ImmuCell Corporation | USD 11.03 | ▼ 0.9% |
| CYAN | Cyanotech Corp. | USD 0.53 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:52 UTC. This page is informational and not investment advice.